| 2025 | 2025 | 2025 | 2024 | 2024 | 2024 | ||
| €’000 | €’000 | €’000 | €’000 | €’000 | €’000 | ||
| Exceptional | Exceptional | ||||||
| Note | Underlying | items* | Total | Underlying | items* | Total | |
Accoya wood revenue | |||||||
Tricoya panel revenue | |||||||
Licence revenue | |||||||
Other revenue | |||||||
Total revenue | 3 | ||||||
Cost of sales | ( | ( | ( | ( | |||
Gross profit | |||||||
Other operating costs | 4 | ( | ( | ( | ( | ( | ( |
Operating profit/(loss) | 8 | ( | ( | ( | ( | ( | |
Finance income | 9 | ||||||
Finance expense | 10 | ( | ( | ( | ( | ||
Share of net loss from joint venture | 27 | ( | ( | ( | ( | ||
Loss before taxation | ( | ( | ( | ( | ( | ( | |
Tax expense | 11 | ( | ( | ( | ( | ||
Loss from continuing operations | ( | ( | ( | ( | ( | ( | |
Items that may be reclassified to profit or loss | |||||||
(Loss)/gain arising on translation of foreign operations | ( | ( | |||||
Total other comprehensive (loss)/gain | ( | ( | |||||
Total comprehensive loss for the year | ( | ( | ( | ( | ( | ( | |
| Total comprehensive loss for the year | |||||||
| is attributable to: | |||||||
Owners of Accsys Technologies PLC | ( | ( | ( | ( | ( | ( | |
Total comprehensive loss for the year | ( | ( | ( | ( | ( | ( | |
Basic loss per ordinary share | 12 | €( | €( | €( | €( | ||
Diluted loss per ordinary share | 12 |
| 2025 | 2024 | ||
| Note | €’000 | €’000 | |
| Non-current assets | |||
Intangible assets | 14 | ||
Investment in joint venture | 27 | ||
Property, plant and equipment | 15 | ||
Right of use assets | 16 | ||
Financial asset at fair value through profit or loss | 17 | ||
| Current assets | |||
Inventories | 20 | ||
Trade and other receivables | 21 | ||
Cash and cash equivalents | 28 | ||
Corporation tax receivable | |||
| Current liabilities | |||
Trade and other payables | 23 | ( | ( |
Obligation under lease liabilities | 16 | ( | ( |
Short term borrowings | 28 | ( | |
Corporation tax payable | ( | ( | |
( | ( | ||
Net current assets | |||
| Non-current liabilities | |||
Obligation under lease liabilities | 16 | ( | ( |
Other long term borrowings | 28 | ( | ( |
Financial guarantee | 30 | ||
Financial liability at amortised cost | 22 | ( | |
( | ( | ||
Net assets | |||
| Equity | |||
Share capital | 24 | ||
Share premium account | |||
Other reserves | 25 | ||
Accumulated loss | ( | ( | |
Own shares | ( | ( | |
Foreign currency translation reserve | |||
Capital value attributable to owners of Accsys Technologies PLC | |||
Non-controlling interest in subsidiaries | 26 | ||
Total equity |
| Total equity | |||||||||
| Foreign | attributable | ||||||||
| Share | currency | to equity | Non- | ||||||
| capital | Share | Other | Own | translation | Accumulated | shareholders of | Controlling | Total | |
| Ordinary | premium | reserves | Shares | reserve | Loss | the Company | interests | Equity | |
| €000 | €000 | €000 | €000 | €000 | €000 | €000 | €000 | €000 | |
Balance at 1 April 2023 | ( | ( | |||||||
Loss for the year | ( | ( | ( | ||||||
| Other comprehensive gain | |||||||||
for the year | |||||||||
Share based payments | |||||||||
Shares issued | |||||||||
Premium on shares issued | |||||||||
Share issue costs | ( | ( | ( | ||||||
Balance at 31 March 2024 | ( | ( | |||||||
Loss for the year | ( | ( | ( | ||||||
| Other comprehensive loss | |||||||||
forthe year | ( | ( | ( | ||||||
Share based payments | |||||||||
Shares issued | ( | ||||||||
Premium on shares issued | ( | ||||||||
Share issue costs | |||||||||
| Foreign exchange | |||||||||
hedgemovement | ( | ( | ( | ||||||
Balance at 31 March 2025 | ( | ( |
| 2025 | 2024 | ||
| Note | €’000 | €’000 | |
Loss before taxation | ( | ( | |
| Adjustments for: | |||
Amortisation of intangible assets | 8 | ||
Depreciation of property, plant and equipment, and right of use assets | 8 | ||
Loss from liquidation of Tricoya UK Ltd | 5 | ||
Net finance expense | 10 | ||
Equity-settled share-based payment expenses | 13 | ||
Accsys portion of Licence fee received from joint venture | 27 | ||
Share of net loss of joint venture | 27 | ||
Currency translation losses | |||
Cash inflows from operating activities before changes in working capital | |||
(Increase)/decrease in trade and other receivables | 21 | ( | |
(Increase)/decrease in inventories | 20 | ( | |
Decrease in trade and other payables | 23 | ( | ( |
Net cash generated from operating activities before tax | |||
Tax (paid)/received | 11 | ( | |
Net cash generated from operating activities | |||
| Cash flows from investing activities | |||
Proceeds from disposal of property, plant and equipment | |||
Investment in property, plant and equipment | 15 | ( | ( |
Cash disposed of from liquidation of Tricoya UK Ltd | ( | ||
Investment in intangible assets | 14 | ( | ( |
Investment in joint venture | 27 | ( | ( |
Net cash used in investing activities | ( | ( | |
| Cash flows from financing activities | |||
Proceeds from loans | |||
Other finance costs | ( | ( | |
Interest paid | ( | ( | |
Interest received | |||
Repayment of lease liabilities | 16 | ( | ( |
Repayment of loans/rolled up interest | ( | ||
Proceeds from issue of share capital | |||
Share issue costs | ( | ( | |
Net cash (used in)/generated from financing activities | ( | ||
Net (decrease)/increase in cash and cash equivalents | ( | ||
Effect of exchange rate changes on cash and cash equivalents | ( | ||
Opening cash and cash equivalents | |||
Closing cash and cash equivalents |
| Accoya Segment | ||||||
| Year ended | Year ended | Year ended | Year ended | Year ended | Year ended | |
| 31 March | 31 March | 31 March | 31 March | 31 March | 31 March | |
| 2025 | 2025 | 2025 | 2024 | 2024 | 2024 | |
| Exceptional | Exceptional | |||||
| Underlying | items | TOTAL | Underlying | items | TOTAL | |
| €’000 | €’000 | €’000 | €’000 | €’000 | €’000 | |
Accoya wood revenue | 124,047 | – | 124,047 | 123,139 | – | 123,139 |
Tricoya panel revenue | 3,698 | – | 3,698 | 4,134 | – | 4,134 |
Licence revenue | 375 | – | 375 | 77 | – | 77 |
Other revenue | 8,512 | – | 8,512 | 8,820 | – | 8,820 |
Total Revenue | 136,632 | – | 136,632 | 136,170 | – | 136,170 |
Cost of sales | (95,205) | – | (95,205) | (95,287) | – | (95,287) |
Gross profit | 41,427 | – | 41,427 | 40,883 | – | 40,883 |
Other operating costs | (30,084) | (12,030) | (42,114) | (37,310) | (8,200) | (45,510) |
Operating profit/(loss) | 11,343 | (12,030) | (687) | 3,573 | (8,200) | (4,627) |
Operating profit/(loss) | 11,343 | (12,030) | (687) | 3,573 | (8,200) | (4,627) |
Depreciation and amortisation | 9,219 | – | 9,219 | 9,579 | – | 9,579 |
Profit on disposal of assets | – | (12) | (12) | – | – | – |
Impairment | – | 18,320 | 18,320 | – | 7,000 | 7,000 |
Gain on disposal of investment | – | (10,382) | (10,382) | – | – | – |
EBITDA | 20,562 | (4,104) | 16,458 | 13,152 | (1,200) | 11,952 |
| Year ended | Year ended | |
| 31 March | 31 March | |
| 2025 | 2024 | |
| €’000 | €’000 | |
Operating profit | 11,343 | 3,573 |
Share of Accoya USA EBIT | (9,621) | (3,993) |
Adjusted EBIT | 1,722 | (420) |
| Year ended | Year ended | |
| 31 March | 31 March | |
| 2025 | 2024 | |
| €’000 | €’000 | |
Underlying EBITDA | 20,562 | 13,152 |
Share of Accoya USA EBITDA | (6,045) | (3,724) |
Adjusted EBITDA | 14,517 | 9,428 |
| Corporate Segment | ||||||
| Year ended | Year ended | Year ended | Year ended | Year ended | Year ended | |
| 31 March | 31 March | 31 March | 31 March | 31 March | 31 March | |
| 2025 | 2025 | 2025 | 2024 | 2024 | 2024 | |
| Exceptional | Exceptional | |||||
| Underlying | items | TOTAL | Underlying | items | TOTAL | |
| €’000 | €’000 | €’000 | €’000 | €’000 | €’000 | |
Accoya wood revenue | – | – | – | – | – | – |
Licence revenue | – | – | – | – | – | – |
Other revenue | – | – | – | – | – | – |
Total Revenue | – | – | – | – | – | – |
Cost of sales | – | – | – | – | – | – |
Gross result | – | – | – | – | – | – |
Other operating costs | (3,694) | – | (3,694) | (4,617) | – | (4,617) |
Operating profit/(loss) | (3,694) | – | (3,694) | (4,617) | – | (4,617) |
Operating profit/(loss) | (3,694) | – | (3,694) | (4,617) | – | (4,617) |
Depreciation and amortisation | – | – | – | – | – | – |
EBITDA | (3,694) | – | (3,694) | (4,617) | – | (4,617) |
| Total | ||||||
| Year ended | Year ended | Year ended | Year ended | Year ended | Year ended | |
| 31 March | 31 March | 31 March | 31 March | 31 March | 31 March | |
| 2025 | 2025 | 2025 | 2024 | 2024 | 2024 | |
| Exceptional | Exceptional | |||||
| Underlying | items | TOTAL | Underlying | items | TOTAL | |
| €’000 | €’000 | €’000 | €’000 | €’000 | €’000 | |
Accoya wood revenue | 124,047 | – | 124,047 | 123,139 | – | 123,139 |
Tricoya panel revenue | 3,698 | – | 3,698 | 4,134 | – | 4,134 |
Licence revenue | 375 | – | 375 | 77 | – | 77 |
Other revenue | 8,512 | – | 8,512 | 8,820 | – | 8,820 |
Total Revenue | 136,632 | – | 136,632 | 136,170 | – | 136,170 |
Cost of sales | (95,205) | – | (95,205) | (95,287) | – | (95,287) |
Gross profit | 41,427 | – | 41,427 | 40,883 | – | 40,883 |
Other operating costs | (33,778) | (12,030) | (45,808) | (41,927) | (8,200) | (50,127) |
Operating profit/(loss) | 7,649 | (12,030) | (4,381) | (1,044) | (8,200) | (9,244) |
Finance income | 304 | – | 304 | 138 | – | 138 |
Finance expense | (5,960) | 1,102 | (4,858) | (4,418) | 530 | (3,888) |
Investment in joint venture | (11,871) | – | (11,871) | (4,100) | – | (4,100) |
Loss before taxation | (9,878) | (10,928) | (20,806) | (9,424) | (7,670) | (17,094) |
| Year ended | Year ended | Year ended | Year ended | Year ended | Year ended | |
| 31 March | 31 March | 31 March | 31 March | 31 March | 31 March | |
| 2025 | 2025 | 2025 | 2024 | 2024 | 2024 | |
| Exceptional | Exceptional | |||||
| items | TOTAL | items | TOTAL | |||
| €’000 | €’000 | €’000 | €’000 | €’000 | €’000 | |
Operating profit/(loss) | 7,649 | (12,030) | (4,381) | (1,044) | (8,200) | (9,244) |
Depreciation and amortisation | 9,219 | – | 9,219 | 9,579 | – | 9,579 |
Profit on disposal of assets | – | (12) | (12) | – | – | – |
Impairment | – | 18,320 | 18,320 | – | 7,000 | 7,000 |
Gain on disposal of investment | – | (10,382) | (10,382) | – | – | – |
EBITDA | 16,868 | (4,104) | 12,764 | 8,535 | (1,200) | 7,335 |
| Year ended | Year ended | |
| 31 March | 31 March | |
| 2025 | 2024 | |
| €’000 | €’000 | |
Operating profit/(loss) | 7,649 | (1,044) |
Share of Accoya USA EBIT | (9,621) | (3,993) |
Adjusted EBIT | (1,972) | (5,037) |
| Year ended | Year ended | |
| 31 March | 31 March | |
| 2025 | 2024 | |
| €’000 | €’000 | |
Underlying EBITDA | 16,868 | 8,535 |
Share of Accoya USA EBITDA | (6,045) | (3,724) |
Adjusted EBITDA | 10,823 | 4,811 |
| 2025 | 2024 | |
| €’000 | €’000 | |
UK and Ireland | 54,103 | 46,903 |
Rest of Europe | 51,276 | 47,364 |
Americas | 15,921 | 28,878 |
Rest of World | 15,332 | 13,025 |
136,632 | 136,170 |
| Accoya | Corporate | TOTAL | Accoya | Corporate | TOTAL | |
| 2025 | 2025 | 2025 | 2024 | 2024 | 2024 | |
| €’000 | €’000 | €’000 | €’000 | €’000 | €’000 | |
Non-current assets | 115,505 | 1,661 | 117,166 | 137,927 | 1,016 | 138,943 |
Current assets | 52,142 | 11,645 | 63,787 | 52,321 | 18,711 | 71,032 |
Current liabilities | (20,455) | (9,779) | (30,234) | (22,105) | (4,101) | (26,206) |
Net current assets/(liabilities) | 31,687 | 1,866 | 33,553 | 30,216 | 14,610 | 44,826 |
Non-current liabilities | (2,663) | (50,734) | (53,397) | (9,817) | (55,137) | (64,954) |
Net assets/(liabilities) | 144,529 | (47,207) | 97,322 | 158,326 | (39,511) | 118,815 |
| 2025 | 2024 | |
| €’000 | €’000 | |
UK | 4,169 | 23,129 |
Other countries | 108,766 | 111,583 |
Un-allocated – Goodwill | 4,231 | 4,231 |
117,166 | 138,943 |
| 2025 | 2024 | |
| €’000 | €’000 | |
Sales and marketing | 4,805 | 6,044 |
Research and development | 1,190 | 1,490 |
Other operating costs | 4,392 | 11,731 |
Administration costs | 14,172 | 13,083 |
Exceptional items* | 4,092 | 1,200 |
Other operating costs excluding depreciation, amortisation, impairment and gains on disposals | 28,651 | 33,548 |
Depreciation and amortisation | 9,219 | 9,579 |
Impairment loss – exceptional items* | 18,320 | 7,000 |
Gain on disposal of investment* | (10,382) | – |
Total other operating costs | 45,808 | 50,127 |
| 2025 | 2024 | |
| €’000 | €’000 | |
Impairment of the Tricoya segment assets | (18,320) | (7,000) |
Hull closure costs | (4,092) | – |
Gain on disposal of investment | 10,382 | – |
Restructuring costs | – | (1,200) |
Total exceptional operating costs | (12,030) | (8,200) |
Foreign exchange differences on Corporate USO cash held for investment in to USA JV | – | 249 |
Revaluation/recognition of Valuation Recovery Instrument ‘VRI’ liability | 1,102 | 281 |
Total exceptional financing | 1,102 | 530 |
Total exceptional items | (10,928) | (7,670) |
| 2025 | 2024 | |
| €’000 | €’000 | |
| Staff costs (including Directors) consist of: | ||
Wages and salaries | 15,402 | 18,508 |
Social security costs | 2,407 | 3,044 |
Other pension costs | 1,101 | 1,357 |
Share based payments | 1,734 | 1,494 |
20,644 | 24,403 |
2025 | 2024 | |
Sales and marketing, administration, research and engineering | 120 | 137 |
Operating | 95 | 99 |
215 | 236 |
| 2025 | 2024 | |
| €’000 | €’000 | |
| Directors’ remuneration consists of: | ||
Directors’ emoluments | 1,867 | 1,450 |
Company contributions to money purchase pension schemes | 57 | 52 |
1,924 | 1,502 |
| 2025 | 2025 | Share | 2024 | 2024 | Share | |||||
| Salary, bonus | based | Salary, bonus | based | |||||||
| and short | 2025 | payments | 2025 | and short | 2024 | payments | 2024 | |||
| term benefits | Pension | charge | Total | term benefits | Pension | charge | Total | |||
| €’000 | €’000 | €’000 | €’000 | €’000 | €’000 | €’000 | €’000 | |||
Jelena Arsic van Os | 916 | 37 | 129 | 1,082 | 477 | 27 | 171 | 675 | ||
Steven Salo | 196 | 3 | 22 | 221 | 401 | 25 | 27 | 453 | ||
Sameet Vohra | 309 | 13 | 44 | 366 | – | – | – | – | ||
Hans Pauli | 130 | 4 | 4 | 138 | – | – | – | – | ||
1,551 | 57 | 199 | 1,807 | 878 | 52 | 198 | 1,128 |
| 2025 | 2024 | ||
| €’000 | €’000 | ||
| This has been arrived at after charging: | |||
Staff costs (note 6) | 20,644 | 24,403 | |
Depreciation of property, plant and equipment, and right of use assets | 8,171 | 8,751 | |
Impairment | 18,320 | 7,000 | |
Amortisation of intangible assets | 1,048 | 828 | |
Short term lease rentals | 91 | 40 | |
Foreign exchange losses | 129 | 108 | |
Research & development (excluding staff costs) | 452 | 700 | |
Fees payable to the Company’s auditors for the audit of the Group’s annual financial statements | 295 | 193 | |
| Fees payable to the Company’s auditors for other services: | |||
• | audit of the Company’s subsidiaries pursuant to legislation | 104 | 212 |
• | other assurance services | 53 | – |
Fees payable to Component auditors for audit of subsidiaries | 201 | 190 | |
Fees payable to Component auditors for audit of joint ventures | 134 | – | |
Total audit and audit related services: | 787 | 595 |
| 2025 | 2024 | |
| €’000 | €’000 | |
Interest receivable on bank and other deposits | 304 | 138 |
| 2025 | 2024 | |
| €’000 | €’000 | |
Interest on loans | 4,667 | 3,536 |
Interest on lease liabilities | 356 | 292 |
Other finance expenses | 937 | 590 |
Total underlying finance expenses | 5,960 | 4,418 |
| Exceptional items | ||
Foreign exchange (gain) on Corporate USD cash held for investment in to USA JV | – | (249) |
Revaluation/recognition of Valuation Recovery Instrument ‘VRI’ | (1,102) | (281) |
Total Finance expense/(income) | 4,858 | 3,888 |
| 2025 | 2024 | |
| €’000 | €’000 | |
| (a) Tax recognised in the statement of comprehensive income comprises: | ||
| Current tax charge | ||
UK corporation tax on losses for the year | 653 | – |
Research and development tax expense in respect of prior years | – | 121 |
653 | 121 | |
Overseas tax at rate of 15% | 8 | 8 |
Overseas tax at rate of 25% | 1,383 | 636 |
| Deferred Tax | ||
Utilisation of deferred tax asset | – | – |
Total tax charge reported in the statement of comprehensive income | 2,044 | 765 |
| 2025 | 2024 | |
| €’000 | €’000 | |
(b) The standard rate of corporation tax applied to the UK reported profit is 25%. Taxation for other jurisdictions is calculated at the rates prevailing in the respective jurisdictions. The tax charge for the period is higher than the standard rate of corporation tax in the UK (2025: 25%, 2024: 25%) due to: | ||
Loss before tax | (20,806) | (17,094) |
Expected tax credit at 25% (2024 – 25%) | (5,201) | (4,273) |
Expenses not deductible in determining taxable profit | 699 | – |
ECL impairment (not deductible for tax purposes) | 7,295 | – |
Tricoya segment assets impairment | 878 | 1,750 |
Income not taxable from gain on investment disposal | (2,595) | – |
Tax (income)/losses for which no deferred income tax asset was (utilised)/recognised | (1,197) | 3,159 |
Irrecoverable losses due to deconsolidation | 1,035 | – |
Corporate interest restriction | 481 | – |
Adjustments in relation to prior periods | 641 | – |
Effects of overseas taxation | 8 | 8 |
Research and development tax charge/(credit) in respect of prior years | – | 121 |
Research and development tax (credit) in respect of current year | – | – |
Total tax charge reported in the statement of comprehensive income | 2,044 | 765 |
Deferred tax assets | Deferred tax liabilities | |||
| € ‘000 | 2025 | 2024 | 2025 | 2024 |
At 1 April | 509 | 621 | (509) | (621) |
Credited/(charged) to the consolidated income statement | (98) | (112) | 98 | 112 |
At 31 March | 411 | 509 | (411) | (509) |
| 2025 | 2025 | 2024 | 2024 | |
| Underlying | Total | Underlying | Total | |
| Basic earnings per share | ||||
Weighted average number of ordinary shares in issue (‘000) | 240,086 | 240,086 | 227,911 | 227,911 |
Loss for the year attributable to owners of Accsys Technologies PLC (€’000) | (11,922) | (22,850) | (10,189) | (17,859) |
Basic loss per share | € (0.05) | € (0.10) | € (0.04) | € (0.08) |
| Diluted earnings per share | ||||
Weighted average number of ordinary shares in issue (‘000) | – | – | – | – |
Number of equity options attributable to BGF (see note 29) | – | –* | – | –* |
| Number of equity options attributable to convertible loan note issued | ||||
(see note 28) | – | – | – | – |
| Weighted average number of ordinary shares in issue and potential ordinary | ||||
shares (‘000) | – | – | – | – |
Loss for the year attributable to owners of Accsys Technologies PLC (€’000) | – | – | – | – |
Diluted loss per share | – | –* | – | –* |
| Number of outstanding options | Weighted average remaining | |||
| at 31 March | contractual life, in years | |||
| Date of grant | 2025 | 2024 | 2025 | 2024 |
24 June 2016 (LTIP) | 93,188 | 130,099 | 1.3 | 2.3 |
20 June 2017 (LTIP) | 72,999 | 100,651 | 2.3 | 3.3 |
18 June 2018 (LTIP) | 45,154 | 61,407 | 3.3 | 4.3 |
23 June 2021 (LTIP) 1 | 42,914 | 415,079 | 6.3 | 7.3 |
12 July 2022 (LTIP) | 180,530 | 263,182 | 7.3 | 8.3 |
28 July 2023 (LTIP) | 776,192 | 1,343,091 | 8.3 | 9.3 |
18 July 2024 (LTIP) | 1,265,716 | – | 9.3 | – |
27 November 2024 (LTIP) | 401,516 | – | 9.3 | – |
Total | 2,878,209 | 2,313,509 | 8.3 | 8.0 |
| Weighted | ||
| average | ||
| exercise | ||
price | Number | |
Outstanding at 01 April 2023 | € 0.00 | 2,574,403 |
Granted during the year | € 0.00 | 1,438,216 |
Forfeited during the year | € 0.00 | (1,131,001) |
Exercised during the year | € 0.00 | (568,109) |
Expired during the year | € 0.00 | – |
Outstanding at 31 March 2024 | € 0.00 | 2,313,509 |
Granted during the year | € 0.00 | 1,963,768 |
Forfeited during the year | € 0.00 | (1,318,252) |
Exercised during the year | € 0.00 | (80,816) |
Expired during the year | € 0.00 | – |
Outstanding at 31 March 2025 | € 0.00 | 2,878,209 |
Metric | Weighting (% of award) | Threshold | Maximum |
Vesting (% of maximum) | 25% | 100% | |
| Cumulative Sales Volume (FY23 to FY25) (m | ) 25% | 206,000 | 232,000 |
Average Gross contribution (%) | 25% | 49.60% | 55% |
Share performance compared to AIM Index | 40% | Median | Upper quartile |
ESG – improvement in reporting ratings | 10% | 15% improvement in | 20% improvement in |
| S&P ESG score over the | S&P ESG score over the | ||
| three-year period | three-year period |
| Element B | Element D | |||
| Element A | (Gross Contribution | Element C | (ESG Reporting | |
| Element | (Sales volume growth) | %) | (Share price growth) | Metrics) |
Grant date | 12 Jul 22 | 12 Jul 22 | 12 Jul 22 | 12 Jul 22 |
Share price at grant date (€) | 1.21 | 1.21 | 1.21 | 1.21 |
Exercise price (€) | 0.00 | 0.00 | 0.00 | 0.00 |
Expected life (years) | 3 | 3 | 3 | 3 |
Contractual life (years) | 10 | 10 | 10 | 10 |
Vesting conditions (Details set out above) | Sales volume | Gross Contribution % | Share price | ESG reporting metrics |
Risk free rate | 0.45% | 0.45% | 0.45% | 0.45% |
Expected volatility | 20% | 20% | 20% | 20% |
Expected dividend yield | 0% | 0% | 0% | 0% |
Fair value of option | € 1.21 | € 1.21 | € 0.90 | € 1.21 |
Metric | Weighting (% of award) | Threshold | Maximum |
Vesting (% of maximum) | 25% | 100% | |
Cumulative Sales Revenue (FY24 to FY26) (€) | 45% | €500m | €600m |
Underlying EBITDA per share (€) | 45% | 0.18 | 0.20 |
ESG – improvement in reporting ratings | 10% | 6% improvement in | 9% improvement in |
| S&P ESG score over the | S&P ESG score over the | ||
| three-year period | three-year period |
| Element B | |||
| Element A | (Underlying EBITDA | Element D | |
| Element | (Cumulative sales revenue) | per share) | (ESG Reporting Metrics) |
Grant date | 28 Jul 23 | 28 Jul 23 | 28 Jul 23 |
Share price at grant date (€) | 1.24 | 1.24 | 1.24 |
Exercise price (€) | 0.00 | 0.00 | 0.00 |
Expected life (years) | 3 | 3 | 3 |
Contractual life (years) | 10 | 10 | 10 |
Vesting conditions (Details set out above) | Sales revenue | EBITDA per share | ESG reporting metrics |
Risk free rate | 2.755% | 2.755% | 2.755% |
Expected volatility | 20% | 20% | 20% |
Expected dividend yield | 0% | 0% | 0% |
Fair value of option | € 1.24 | € 1.24 | € 1.24 |
Metric | Weighting (% of award) | Threshold | Maximum |
Vesting (% of maximum) | 25% | 100% | |
Share performance compared to AIM Index | 30% | Median | Top quartile |
EBITDA per share in FY27 | 40% | €0.07 | €0.13 |
Cumulative Cash generation | 30% | €0m cash inflow | €10m cash inflow |
| Element A | Element B | Element D | |
| Element | (Share price growth) | (Adjusted EBITDA per share) | (Cumulative Cash generation) |
Grant date | 18 Jul 24 | 18 Jul 24 | 18 Jul 24 |
Share price at grant date (€) | 0.65 | 0.65 | 0.65 |
Exercise price (€) | 0.00 | 0.00 | 0.00 |
Expected life (years) | 3 | 3 | 3 |
Contractual life (years) | 10 | 10 | 10 |
Vesting conditions (Details set out above) | Share price | EBITDA | Cash |
Risk free rate | 2.53% | 2.53% | 2.53% |
Expected volatility | 20% | 20% | 20% |
Expected dividend yield | 0% | 0% | 0% |
Fair value of option | € 0.65 | € 0.65 | € 0.65 |
| Internal | Intellectual | |||
| development | property | |||
| costs | rights | Goodwill | Total | |
| €’000 | €’000 | €’000 | €’000 | |
| Cost | ||||
At 1 April 2023 | 7,699 | 75,372 | 4,231 | 87,302 |
Additions | 50 | 335 | – | 385 |
At 31 March 2024 | 7,749 | 75,707 | 4,231 | 87,687 |
Additions | – | 134 | – | 134 |
At 31 March 2025 | 7,749 | 75,841 | 4,231 | 87,821 |
| Accumulated amortisation and impairment | ||||
At 1 April 2023 | 3,279 | 73,532 | – | 76,811 |
Amortisation | 399 | 429 | – | 828 |
At 31 March 2024 | 3,678 | 73,961 | – | 77,639 |
Amortisation | 375 | 673 | – | 1,048 |
Impairment loss | 2,438 | 538 | – | 2,976 |
At 31 March 2025 | 6,491 | 75,172 | – | 81,663 |
| Net book value | ||||
At 31 March 2025 | 1,258 | 669 | 4,231 | 6,158 |
At 31 March 2024 | 4,071 | 1,746 | 4,231 | 10,048 |
At 31 March 2023 | 4,420 | 1,840 | 4,231 | 10,491 |
| Leased land | ||||
| and | Plant and | Office | ||
| buildings | machinery | equipment | Total | |
| €’000 | €’000 | €’000 | €’000 | |
| Cost or valuation | ||||
At 1 April 2023 | 17,976 | 208,821 | 4,697 | 231,494 |
Additions | – | 1,779 | 333 | 2,112 |
Reclassification | – | (3,669) | (451) | (4,120) |
At 31 March 2024 | 17,976 | 206,931 | 4,579 | 229,486 |
Additions | – | 1,325 | 430 | 1,755 |
Disposals | – | (109,254) | (340) | (109,594) |
Reclassification | – | – | – | – |
At 31 March 2025 | 17,976 | 99,002 | 4,669 | 121,647 |
| Accumulated depreciation and impairment | ||||
At 1 April 2023 | 1,711 | 120,892 | 2,840 | 125,443 |
Charge for the year | 358 | 6,847 | 482 | 7,687 |
Foreign currency translation loss | – | – | 2 | 2 |
Impairment loss | – | 7,000 | – | 7,000 |
Reclassification | – | (3,669) | (451) | (4,120) |
At 31 March 2024 | 2,069 | 131,070 | 2,873 | 136,012 |
Charge for the year | 379 | 6,203 | 351 | 6,933 |
Depreciation on disposals | – | (109,184) | (340) | (109,524) |
Foreign exchange hedge movement | – | 337 | – | 337 |
Foreign currency translation loss | – | – | 3 | 3 |
Impairment loss | – | 14,246 | 47 | 14,293 |
At 31 March 2025 | 2,448 | 42,672 | 2,934 | 48,054 |
| Net book value | ||||
At 31 March 2025 | 15,528 | 56,330 | 1,735 | 73,593 |
At 31 March 2024 | 15,907 | 75,861 | 1,706 | 93,474 |
At 31 March 2023 | 16,265 | 87,929 | 1,857 | 106,051 |
| Right-of-use assets | ||
| 2025 | 2024 | |
| €’000 | €’000 | |
| Right-of-use assets | ||
Properties | 2,424 | 2,762 |
Plant equipment | 1,137 | 974 |
3,561 | 3,736 |
| Present value of minimum | ||
| lease payments | ||
| 2025 | 2024 | |
| €’000 | €’000 | |
| Amounts payable under lease liabilities: | ||
Within one year | 1,126 | 771 |
In the second to fifth years inclusive | 2,892 | 2,364 |
After five years | 1,580 | 3,242 |
Less: future finance charges | (1,315) | (2,039) |
Present value of lease obligations | 4,283 | 4,338 |
| Minimum lease payments | ||
| 2025 | 2024 | |
| €’000 | €’000 | |
| Amounts payable under lease liabilities: | ||
Within one year | 961 | 690 |
In the second to fifth years inclusive | 1,799 | 1,454 |
After five years | 1,523 | 2,194 |
Present value of lease obligations | 4,283 | 4,338 |
| 2025 | 2024 | |
| €’000 | €’000 | |
| Depreciation charge of right-of-use assets | ||
Properties | 628 | 428 |
Plant equipment | 610 | 636 |
1,238 | 1,064 | |
Interest expense (included in finance cost) | 356 | 292 |
Expense relating to short-term leases (included in cost of goods sold and administrative expenses) | 44 | 22 |
| Expense relating to leases of low-value assets that are not shown above as short-term leases | ||
(included in administrative expenses) | 47 | 18 |
| 2025 | 2024 | |
| €’000 | €’000 | |
Shares held in Cleantech Building Materials PLC | – | – |
| 2025 | 2024 | |
| €’000 | €’000 | |
Raw materials and work in progress | 18,822 | 18,214 |
Finished goods | 11,941 | 7,529 |
30,763 | 25,743 |
| 2025 | 2024 | |
| €’000 | €’000 | |
Trade receivables | 12,881 | 14,044 |
Other receivables | 509 | 1,616 |
VAT receivable | 1,106 | 874 |
Prepayments | 1,105 | 1,078 |
15,601 | 17,612 |
| 2025 | 2024 | |
| €’000 | €’000 | |
Up to 30 days overdue | 974 | 714 |
Over 30 days and up to 60 days overdue | 25 | 117 |
Over 60 days and up to 90 days overdue | 13 | 17 |
Over 90 days overdue | 7 | – |
1,019 | 848 |
| 2025 | 2024 | |
| €’000 | €’000 | |
Value Recovery Instrument (‘VRI’) | – | 1,102 |
| 2025 | 2024 | |
| €’000 | €’000 | |
Trade payables | 8,436 | 11,824 |
Other taxes and social security payable | 614 | 847 |
Accruals and deferred income | 7,540 | 6,126 |
16,590 | 18,797 |
| 2025 | 2024 | |
| €’000 | €’000 | |
| Allotted – Equity share capital | ||
240,445,567 ordinary shares of €0.05 each (2024: 239,518,372 ordinary shares of €0.05 each) | 12,022 | 11,976 |
12,022 | 11,976 |
| Capital | Hedging | ||||
| redemption | Merger | effectiveness | Other | Total other | |
| reserve | reserve | reserve | reserve | reserves | |
| €000 | €000 | €000 | €000 | €000 | |
Balance at 1 April 2023 | 148 | 106,707 | 337 | 7,551 | 114,743 |
Total comprehensive income for the period | – | – | – | – | – |
Balance at 31 March 2024 | 148 | 106,707 | 337 | 7,551 | 114,743 |
Foreign exchange hedge movement | – | – | (337) | – | (337) |
Balance at 31 March 2025 | 148 | 106,707 | – | 7,551 | 114,406 |
| 2025 | 2024 | |
| €’000 | €’000 | |
Opening balance | 31,685 | 30,859 |
Investment in Accoya USA | 14,490 | 4,926 |
Less: Accsys proportion (60%) of Licence fee received | (450) | – |
Loss for the year | (11,871) | (4,100) |
Closing balance | 33,854 | 31,685 |
| 2025 | 2024 | |
| €’000 | €’000 | |
Net assets of Accoya USA (USD) | 65,003 | 60,002 |
60% of net assets of Accoya USA (Eur) | 36,024 | 33,359 |
Less: Accsys proportion (60%) of Licence fee received to date | (1,950) | (1,500) |
Foreign exchange movements | (220) | (174) |
Closing balance | 33,854 | 31,685 |
| 2025 | 2024 | |
| Accoya USA statement of comprehensive income: | €’000 | €’000 |
Total revenue | 18,089 | – |
Cost of sales | (17,939) | – |
Gross profit | 150 | – |
Operating costs | (16,185) | (6,653) |
Operating loss | (16,035) | (6,653) |
Interest payable | (3,750) | (179) |
Loss before taxation | (19,785) | (6,832) |
Tax expense | – | – |
Total comprehensive loss for the financial year | (19,785) | (6,832) |
Accsys share (60%) of US JV EBITDA | (6,045) | (3,724) |
Accsys share (60%) of US JV EBIT | (9,621) | (3,993) |
Accsys share (60%) of US JV total loss from operations | (11,871) | (4,100) |
| 2025 | 2024 | |
| €’000 | €’000 | |
| Non-current assets | ||
Property, plant and equipment | 126,542 | 122,662 |
Right of use assets | 6,328 | 6,919 |
132,870 | 129,581 | |
| Current assets | ||
Inventories | 9,021 | 1,201 |
Trade and other receivables | 1,162 | 114 |
Cash and cash equivalents | 1,675 | 6,089 |
11,858 | 7,404 | |
| Current liabilities | ||
Trade and other payables | (2,879) | (10,508) |
Obligation under lease liabilities | (6,560) | (491) |
(9,439) | (10,999) | |
Net current assets/(liabilities) | 2,419 | (3,595) |
| Non-current liabilities | ||
Obligation under lease liabilities | – | (6,635) |
Other long term borrowing | (75,249) | (63,701) |
(75,249) | (70,336) | |
Net assets | 60,040 | 55,650 |
Value attributable to Accsys Technologies | 36,024 | 33,390 |
| 2025 | 2024 | |
| €’000 | €’000 | |
Cash flows from operating activities | (26,441) | (4,679) |
Cash flows from investing activities | (7,978) | (56,553) |
Cash flows from financing activities | 30,004 | 58,620 |
Net decrease in cash and cash equivalents | (4,415) | (2,612) |
| 2025 | 2024 | |||||||
| €’000 | €’000 | |||||||
| Loan obligations | ||||||||
Within one year | 5,625 | – | ||||||
In the second to fifth years inclusive | 50,075 | 32,446 | ||||||
In greater than five years | – | 27,758 | ||||||
Present value of loan obligations | 55,700 | 60,204 | ||||||
| Amounts payable under loan agreements – undiscounted cash flows: | ||||||||
Within one year | 7,285 | 1,646 | ||||||
In the second to fifth years inclusive | 64,505 | 34,294 | ||||||
After five years | – | 43,917 | ||||||
Less future finance charges | (16,090) | (19,653) | ||||||
Present value of loan obligations | 55,700 | 60,204 | ||||||
| Loan reconciliation | 2025 | 2024 | ||||||
| Convertible | Convertible | |||||||
| loan note | loan note | |||||||
| with | with | |||||||
| ABN debt | embedded | NatWest | ABN debt | embedded | NatWest | |||
| facilities | derivative | facility | Total | facilities | derivative | facility | Total | |
| €’000 | €’000 | €’000 | €’000 | €’000 | €’000 | €’000 | €’000 | |
Loan balance | 32,479 | 22,608 | – | 55,087 32,446 21,084 6,674 60,204 |
Metric | Value used 2025 | Input level |
Share price | €0.52 | Level 1 |
Volatility rate | 30.25% | Level 2 |
Interest rate | 9.5% per annum | Level 2 |
Risk free rate | 2.4% per annum | Level 2 |
Discount rate | 16.5% | Level 3 |
| 2025 | 2024 | |
| €’000 | €’000 | |
Cash and cash equivalents | 17,423 | 27,427 |
| Less: | ||
Amounts payable under loan agreements | (55,700) | (60,204) |
Amounts payable under lease liabilities (note 16) | (4,283) | (4,338) |
Net debt | (42,560) | (37,115) |
| 2025 | 2024 | |
| €’000 | €’000 | |
Net cash from operating activities | 10,720 | 7,197 |
Investment in property, plant and equipment and intangible assets | (1,889) | (3,475) |
Free cash flow | 8,831 | 3,722 |
| Fair value | At amortised | At fair value though | At fair value | ||
| 2025/€ ‘000 | hierarchy | cost | profit or loss | through OCI | Total |
| Financial assets | |||||
Trade and other receivables | 13,390 | – | – | 13,390 | |
Cash and cash equivalents | 17,423 | – | – | 17,423 | |
Total | 30,813 | – | – | 30,813 |
| Fair value | At amortised | At fair value though | At fair value | ||
| 2024/€ ‘000 | hierarchy | cost | profit or loss | through OCI | Total |
| Financial assets | |||||
Trade and other receivables | 15,660 | – | – | 15,660 | |
Cash and cash equivalents | 27,427 | – | – | 27,427 | |
Total | 43,087 | – | – | 43,087 |
| Fair value | At amortised | At fair value though | At fair value | ||
| 2025/€ ‘000 | hierarchy | cost | profit or loss | through OCI | Total |
| Financial liabilities | |||||
Borrowings – loans | (55,700) | – | – | (55,700) | |
Lease liabilities | (4,283) | – | – | (4,283) | |
Trade and other payables | (8,436) | – | – | (8,436) | |
Total | (68,419) | – | – | (68,419) |
| Fair value | At amortised | At fair value though | At fair value | ||
| 2024/€ ‘000 | hierarchy | cost | profit or loss | through OCI | Total |
| Financial liabilities | |||||
Borrowings – loans | (60,204) | – | – | (60,204) | |
Lease liabilities | (4,338) | – | – | (4,338) | |
Trade and other payables | (11,824) | – | – | (11,824) | |
Value Recovery Instrument (‘VRI’) | Level 2 | (1,102) | – | – | (1,102) |
Total | (77,468) | – | – | (77,468) |
| 2025 | 2024 | |
| €’000 | €’000 | |
Contracted but not provided for in respect of property, plant and equipment | – | – |
| Registered Company 05534340 | |||
| 2025 | 2024 | ||
| Note | €’000 | €’000 | |
| Non-current assets | |||
Investments in subsidiaries | 4 | 29,643 | 27,283 |
Financial asset at fair value through profit or loss | 5 | – | – |
29,643 | 27,283 | ||
| Current assets | |||
Debtors | 6 | 285,928 | 291,756 |
Cash at bank and in hand | 272 | 21 | |
286,200 | 291,777 | ||
Creditors: amounts falling due within one year | 7 | (18,264) | (12,916) |
Net current assets | 267,936 | 278,861 | |
Creditors: amounts falling due after more than one year | 8/10 | (50,688) | (53,529) |
Net assets | 246,891 | 252,615 | |
| Capital and reserves | |||
Called up Share capital | 11 | 12,022 | 11,976 |
Share premium account | 262,938 | 262,394 | |
Reserve for own shares | (8) | (8) | |
Capital redemption reserve | 148 | 148 | |
Profit and loss account | (28,209) | (21,895) | |
Total shareholders’ funds | 246,891 | 252,615 |
| Share | Capital | Total | ||||
| Called up | premium | redemption | Profit and | shareholders’ | ||
| Share capital | account | reserve | Own shares | lossaccount | funds | |
| €000 | €000 | €000 | €000 | €000 | €000 | |
Balance at 1 April 2023 | 10,963 | 250,717 | 148 | (8) | (17,663) | 244,157 |
Loss for the financial year | – | – | – | – | (5,712) | (5,712) |
Share based payments | – | – | – | – | 1,480 | 1,480 |
Shares issued | 1,013 | – | – | – | – | 1,013 |
Premium on shares issued | – | 12,319 | – | – | – | 12,319 |
Share issue costs | – | (642) | – | – | – | (642) |
Balance at 31 March 2024 | 11,976 | 262,394 | 148 | (8) | (21,895) | 252,615 |
Loss for the financial year | – | – | – | – | (7,480) | (7,480) |
Share based payments | – | – | – | – | 1,747 | 1,747 |
Shares issued | 46 | – | – | – | (46) | – |
Premium on shares issued | – | 535 | – | – | (535) | – |
Share issue costs | – | 9 | – | – | – | 9 |
Balance at 31 March 2025 | 12,022 | 262,938 | 148 | (8) | (28,209) | 246,891 |
| €’000 | |
| Cost | |
At 1 April 2023 | 30,483 |
Additions | – |
Share based payments | 1,480 |
At 31 March 2024 | 31,963 |
Additions | – |
Share based payments | 1,747 |
Fair value of embedded derivative | 613 |
At 31 March 2025 | 34,323 |
| Impairment | |
At 1 April 2023 and 31 March 2024 and 31 March 2025 | 4,680 |
| Net book value | |
At 31 March 2025 | 29,643 |
At 31 March 2024 | 27,283 |
At 31 March 2023 | 25,803 |
| 2025 | 2024 | ||
| % shares | % shares | ||
| and voting | and voting | ||
| rights | rights | ||
| Class | held | held | |
| Subsidiary undertakings | |||
Titan Wood Technology BV (Netherlands) | Ordinary | 100 | 100 |
Titan Wood BV (Netherlands) | Ordinary | 100 | 100 |
Titan Wood Limited (UK) | Ordinary | 100 | 100 |
Titan Wood Inc (USA) | Ordinary | 100 | 100 |
Accsys (Accoya USA) Holdings LLC (USA) | Ordinary | 100 | 100 |
Accsys USA Holdings Inc (USA) | Ordinary | 100 | 100 |
Tricoya Technologies Limited (UK) | Ordinary | 100 | 100 |
Tricoya UK Limited (UK) – in liquidation | Ordinary | 100 | 100 |
Accoya Color UK Limited (UK) | Ordinary | 100 | 100 |
Accsys Jersey Limited (Jersey) | Ordinary | 100 | 100 |
| Joint venture undertakings | |||
Accoya USA LLC (USA) | Ordinary | 60 | 60 |
Titan Wood Technology B.V. * | The provision of technical and engineering services to licensees, and the technical development of |
| acetylation opportunities. | |
Titan Wood B.V. * | The manufacture and sale of Accoya® acetylated wood. |
Titan Wood Limited ** | Establishing global market penetration of Accoya® and Tricoya® as the premium wood and wood |
| elements brands respectively for external applications requiring durability, stability and reliability | |
| through the licensing of the Group’s proprietary process for wood acetylation. | |
Titan Wood Inc. **** | Provision of Sales, Marketing and Technical services. |
Accsys (Accoya USA) Holdings LLC **** | Holdings company |
Accsys USA Holdings Inc **** | Holdings company |
Tricoya Technologies Limted ** | Engaged in the commercialisation of technology for the production of Tricoya® Wood Elements |
| around the world. | |
Tricoya UK Limited ** | The company went into voluntary liquidation on 17 December 2024. The Company has therefore |
| lost control of the entity but still holds 100% of the shares until the liquidation is complete. | |
Accoya Color UK Limited (UK) ** | The manufacture of coloured acetylated wood. |
Accsys Jersey Limited *** | The issuing of convertible loan notes on the Group’s behalf. |
Accoya USA LLC **** | The construction and operation of a manufacturing plant for Accoya® acetylated wood to serve the |
| North American market. |
| 2025 | 2024 | |
| €’000 | €’000 | |
Shares held in Cleantech Building Materials PLC | – | – |
| 2025 | 2024 | |
| €’000 | €’000 | |
Amounts owed by Group undertakings | 285,793 | 291,691 |
Prepayments and accrued income | 68 | 65 |
VAT recoverable | 67 | – |
285,928 | 291,756 |
| 2025 | 2024 | |
| €’000 | €’000 | |
Trade creditors | 435 | 707 |
Amounts owed to Group undertakings | 11,567 | 11,677 |
Obligation under lease liabilities | 7 | 6 |
Short term borrowings | 5,625 | – |
VAT | – | 62 |
Accruals and deferred income | 630 | 464 |
18,264 | 12,916 |
| 2025 | 2024 | |
| €’000 | €’000 | |
Amounts owed to Group undertakings | 23,834 | 21,084 |
| Minimum lease payments | ||
| 2025 | 2024 | |
| €’000 | €’000 | |
| Amounts payable under lease liabilities: | ||
Within one year | 7 | 6 |
Less: future finance charges | – | – |
Present value of lease obligations | 7 | 6 |
| 2025 | 2024 | |
| €’000 | €’000 | |
| Loan obligations | ||
Within one year | 5,625 | – |
In the second to fifth years inclusive | 26,854 | 32,445 |
In greater than five years | – | – |
Present value of loan obligations | 32,479 | 32,445 |
| 2025 | 2024 | |
| €’000 | €’000 | |
| Amounts payable under loan agreements: | ||
Within one year | 7,285 | – |
In the second to fifth years inclusive | 28,996 | 35,940 |
After five years | – | – |
Less future finance charges | (3,802) | (3,495) |
Present value of loan obligations | 32,479 | 32,445 |
| 2025 | 2024 | |
| €’000 | €’000 | |
| Allotted – Equity share capital | ||
240,445,567 ordinary shares of €0.05 each (2024: 239,518,372 ordinary shares of €0.05 each) | 12,022 | 11,976 |
12,022 | 11,976 |
| 2025 | 2024 | |
| €’000 | €’000 | |
Loss for the financial year | (7,480) | (5,712) |
Share based payments charged to subsidiaries | 1,747 | 1,480 |
Proceeds from issue of shares | – | 13,332 |
Share issue costs | 9 | (642) |
Net (decrease)/increase in shareholders’ funds | (5,724) | 8,458 |
Opening total shareholders’ funds | 252,615 | 244,157 |
Closing total shareholders’ funds | 246,891 | 252,615 |